share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Samuels Theodore R. II

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施贵宝 | 4：持股变动声明
美股sec公告 ·  04/02 18:46
Moomoo AI 已提取核心信息
Samuels Theodore R. II, associated with Bristol-Myers Squibb (BMY), was involved in a transaction on 03/31/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Samuels to the issuer was not specified, and there was no information provided regarding the number of shares held after the action.
Samuels Theodore R. II, associated with Bristol-Myers Squibb (BMY), was involved in a transaction on 03/31/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Samuels to the issuer was not specified, and there was no information provided regarding the number of shares held after the action.
与百时美施贵宝（BMY）有联系的塞缪尔·西奥多·R.II于2024年3月31日参与了一笔交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。没有具体说明塞缪尔与发行人的关系，也没有提供有关诉讼后持有的股票数量的信息。
与百时美施贵宝（BMY）有联系的塞缪尔·西奥多·R.II于2024年3月31日参与了一笔交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。没有具体说明塞缪尔与发行人的关系，也没有提供有关诉讼后持有的股票数量的信息。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息